financetom
Business
financetom
/
Business
/
Update: Archer-Daniels-Midland Shareholder Calls for CEO Luciano to Depart After 2024 Stock Performance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Archer-Daniels-Midland Shareholder Calls for CEO Luciano to Depart After 2024 Stock Performance
Jan 2, 2025 3:39 AM

06:21 AM EST, 01/02/2025 (MT Newswires) -- (Updates with Archer-Daniels-Midland's ( ADM ) response in the fifth paragraph and recent stock movement in the sixth paragraph.)

Archer-Daniels-Midland's ( ADM ) Chief Executive Juan Luciano is being urged to resign as the market is acting "increasingly negatively" toward the company after a law enforcement probe into its internal pricing of inter-company transactions, shareholder Hartwig Fuchs said in a LinkedIn post Monday.

Fuchs added in the post that the company's share price has fallen "significantly" and there seems "obviously no effort on ADM's part to stop or even reverse this trend. "

"If a highly paid CEO of such an important company cannot manage to provide clarity within a few months - i.e. fully clear up the scandal, communicate with full transparency about what went wrong and what will be done in the future, regain investors trust and, above all, protect the company from long-term damage - then he has to go," the post said.

The company's stock fell almost 31% from December last year.

Archer-Daniels-Midland ( ADM ) declined MT Newswires' request for comment.

Shares of the company edged up by 0.4% in recent Thursday premarket activity.

Price: 50.70, Change: +0.18, Percent Change: +0.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Fiscal Q2 Non-GAAP Earnings, Revenue Increase; 2024 Revenue Outlook Raised -- Shares Rise After Hours
Broadcom Fiscal Q2 Non-GAAP Earnings, Revenue Increase; 2024 Revenue Outlook Raised -- Shares Rise After Hours
Jun 12, 2024
04:55 PM EDT, 06/12/2024 (MT Newswires) -- Broadcom ( AVGO ) reported fiscal Q2 non-GAAP diluted earnings late Wednesday of $10.96 per share, up from $10.32 a year earlier. Analysts polled by Capital IQ expected $10.84 normalized. Net revenue for the quarter that ended May 5 was $12.49 billion, up from $8.73 billion a year earlier. Analysts surveyed by Capital...
Hewlett Packard Enterprise Insider Sold Shares Worth $7,345,541, According to a Recent SEC Filing
Hewlett Packard Enterprise Insider Sold Shares Worth $7,345,541, According to a Recent SEC Filing
Jun 12, 2024
04:51 PM EDT, 06/12/2024 (MT Newswires) -- Antonio F Neri, Director, President and CEO, on June 10, 2024, sold 365,945 shares in Hewlett Packard Enterprise ( HPE ) for $7,345,541. Following the Form 4 filing with the SEC, Neri has control over a total of 2,008,641 shares of the company, with 2,008,641 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1645590/000106299324012508/xslF345X03/form4.xml Price: 21.15,...
Catcha Investment's Shareholders Approve Business Combination with Crown LNG
Catcha Investment's Shareholders Approve Business Combination with Crown LNG
Jun 12, 2024
04:56 PM EDT, 06/12/2024 (MT Newswires) -- Catcha Investment ( CHAA ) said Wednesday its shareholders approved the proposed business combination with Crown LNG. The companies agreed to extend the deadline under the merger agreement until June 28 and expect to close the deal by that date, Catcha said. Shares of the combined business will start trading on the Nasdaq...
Ultragenyx Plans to File Biologics License Application for UX111 Late This Year or Early 2025
Ultragenyx Plans to File Biologics License Application for UX111 Late This Year or Early 2025
Jun 12, 2024
04:50 PM EDT, 06/12/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Wednesday it intends to file late this year or early next year a biologics license application with the US Food and Drug Administration for the accelerated approval of its UX111 novel gene therapy for Sanfilippo syndrome. The Sanfilippo syndrome is a rare, fatal lysosomal storage disease that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved